APO Research
Talk to an analyst

APO RESEARCH · REPORT

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchInvasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Invasive Fungal Disease (IFD) Infection Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market include GOLD MOUNTAINRIVER, Dynamiker Biotechnology, Zhanjiang A&C Biological LTD, IMMY and BioRad, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Invasive Fungal Disease (IFD) Infection Diagnostic Reagent revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market.

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Company

GOLD MOUNTAINRIVER

Dynamiker Biotechnology

Zhanjiang A&C Biological LTD

IMMY

BioRad

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Method

G Experimental

GM Experimental

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Application

Hospital

Laboratory

Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent key companies, revenue, market share, and recent developments.

3. To split the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Invasive Fungal Disease (IFD) Infection Diagnostic Reagent significant trends, drivers, influence factors in global and regions.

6. To analyze Invasive Fungal Disease (IFD) Infection Diagnostic Reagent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent industry.

Chapter 3: Detailed analysis of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Trends Table 2. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Drivers Table 3. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Opportunities and Challenges Table 4. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Restraints Table 5. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue Share by Company (2021-2026) Table 7. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Key Company Manufacturing Base & Headquarters Table 9. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company, Product Type & Application Table 10. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of G Experimental Table 15. Significant Companies of GM Experimental Table 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type (2021-2026) Table 20. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Laboratory Table 23. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application (2021-2026) Table 27. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application (2027-2032) Table 28. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Region (2021-2026) Table 31. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Region (2027-2032) Table 33. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Market Share by Country (2021-2026) Table 36. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Market Share by Country (2027-2032) Table 38. GOLD MOUNTAINRIVER Company Information Table 39. GOLD MOUNTAINRIVER Business Overview Table 40. GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 42. GOLD MOUNTAINRIVER Recent Development Table 43. Dynamiker Biotechnology Company Information Table 44. Dynamiker Biotechnology Business Overview Table 45. Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 47. Dynamiker Biotechnology Recent Development Table 48. Zhanjiang A&C Biological LTD Company Information Table 49. Zhanjiang A&C Biological LTD Business Overview Table 50. Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 52. Zhanjiang A&C Biological LTD Recent Development Table 53. IMMY Company Information Table 54. IMMY Business Overview Table 55. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 57. IMMY Recent Development Table 58. BioRad Company Information Table 59. BioRad Business Overview Table 60. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio Table 62. BioRad Recent Development Table 63. Research Programs/Design for This Report Table 64. Authors List of This Report Table 65. Secondary Sources Table 66. Primary Sources List of Figures Figure 1. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Image Figure 2. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size (2021-2032) & (US$ Million) Figure 4. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. G Experimental Image Figure 8. GM Experimental Image Figure 9. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Laboratory Image Figure 14. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application (2021-2032) Figure 17. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 20. North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 26. South America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • G Experimental
  • GM Experimental
Applications
  • Hospital
  • Laboratory
Companies covered
  • GOLD MOUNTAINRIVER
  • Dynamiker Biotechnology
  • Zhanjiang A&C Biological LTD
  • IMMY
  • BioRad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Dynamics
  1. 2.1 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Trends
  2. 2.2 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Drivers
  3. 2.3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Opportunities and Challenges
  4. 2.4 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Industry Restraints
3 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Company
  1. 3.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Revenue Ranking in 2025
  2. 3.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue by Company (2021-2026)
  3. 3.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Ranking (2024-2026)
  4. 3.4 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Manufacturing Base and Headquarters
  5. 3.5 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Product Type and Application
  6. 3.6 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Type
  1. 4.1 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Type Introduction
  2. 4.1.1 G Experimental
  3. 4.1.2 GM Experimental
  4. 4.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type
  5. 4.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Type (2021-2032)
  7. 4.2.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type (2021-2032)
5 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Market by Application
  1. 5.1 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application
  5. 5.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Application (2021-2032)
  7. 5.2.3 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application (2021-2032)
6 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Regional Value Analysis
  1. 6.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region (2021-2032)
  3. 6.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region: 2021-2026
  4. 6.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032)
  7. 6.3.2 North America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032)
  10. 6.4.2 Europe Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032)
  16. 6.6.2 South America Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Country, 2025 VS 2032
7 Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Country-level Value Analysis
  1. 7.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country (2021-2032)
  3. 7.2.1 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country (2021-2026)
  4. 7.2.2 Global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GOLD MOUNTAINRIVER
  2. 8.1.1 GOLD MOUNTAINRIVER Company Information
  3. 8.1.2 GOLD MOUNTAINRIVER Business Overview
  4. 8.1.3 GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GOLD MOUNTAINRIVER Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  6. 8.1.5 GOLD MOUNTAINRIVER Recent Developments
  7. 8.2 Dynamiker Biotechnology
  8. 8.2.1 Dynamiker Biotechnology Company Information
  9. 8.2.2 Dynamiker Biotechnology Business Overview
  10. 8.2.3 Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dynamiker Biotechnology Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  12. 8.2.5 Dynamiker Biotechnology Recent Developments
  13. 8.3 Zhanjiang A&C Biological LTD
  14. 8.3.1 Zhanjiang A&C Biological LTD Company Information
  15. 8.3.2 Zhanjiang A&C Biological LTD Business Overview
  16. 8.3.3 Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhanjiang A&C Biological LTD Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  18. 8.3.5 Zhanjiang A&C Biological LTD Recent Developments
  19. 8.4 IMMY
  20. 8.4.1 IMMY Company Information
  21. 8.4.2 IMMY Business Overview
  22. 8.4.3 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IMMY Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  24. 8.4.5 IMMY Recent Developments
  25. 8.5 BioRad
  26. 8.5.1 BioRad Company Information
  27. 8.5.2 BioRad Business Overview
  28. 8.5.3 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioRad Invasive Fungal Disease (IFD) Infection Diagnostic Reagent Product Portfolio
  30. 8.5.5 BioRad Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst